Numerate awarded patent

Numerate was recently awarded U.S. Patent 7,856,321 B2, covering the development of models based on phenotypic data. Specifically, it captures the idea that predictions of binding may provide a suitable representation for developing models of phenotypic effects thought to relate to binding events, but where the particular binding interactions underlying the effect may be unknown. We have validated this approach in the laboratory and used it to identify novel anti-bacterial compounds. The results of this work will be presented at the upcoming American Chemical Society meeting in Anaheim.